Skip to content

Study · Measured the body's own peptide · 2017

1 result

Preventive Effects of Poloxamer 188 on Muscle Cell Damage Mechanics Under Oxidative Stress.

Wong SW, Yao Y, Hong Y, Ma Z, Kok SH, Sun S, Cho M, Lee KK, Mak AF

Annals of biomedical engineering20 Sept 2016Cited by 9 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01LabEndogenous levelIn vitro (cells)Mechanism

    In skeletal muscle cells challenged with H2O2 after poloxamer 188 pre-treatment, expression of thymosin beta‑4 stayed largely stable.

    In plain wordsIn muscle cells, the body's own thymosin beta‑4 levels stayed largely stable after poloxamer 188 pre-treatment and oxidative stress.

    Outcome
    No significant changeTβ4 expression under oxidative challenge with P188 pre-treatment
    Study

    n: not reported in source

    skeletal muscle cells
    Outcome group
    Muscle injury and repair · Musculoskeletal

    Source sentences

    Summary
    The actin polymerization dynamics largely remained stable in term of the expression of cofilin, thymosin beta 4 and profilin.
    2 context sentences
    Summary · context
    It was found that with 1 mM P188 pre-treatment for 1 h, skeletal muscle cells could maintain their compressive damage threshold.
    Summary · context
    In this study, we investigated the preventive effect of poloxamer 188 (P188) on skeletal muscle cells against extrinsic oxidative challenges (H2O2).

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.